Limbic Encephalitis With Dpp6 Antibodies C4750833
An autoimmune condition where antibodies attack brain cells in the limbic system. It causes memory problems, confusion, and sometimes seizures. Treatment uses immune-suppressing medications and varies by individual response.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Memory impairment
(neurologic)Psychiatric symptoms
(neurologic)Autonomic dysfunction
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Immunotherapy
First-line immunotherapy using corticosteroids such as intravenous methylprednisolone followed by oral taper. For refractory cases, second-line agents like rituximab or cyclophosphamide may be considered.
Anticonvulsant therapy
Antiepileptic medications to control seizures which are common in limbic encephalitis. Drug selection based on seizure type and potential drug interactions with immunotherapy.
Additional treatment options
Plasma exchange
Therapeutic plasma exchange to remove pathogenic antibodies from circulation, often used in conjunction with immunotherapy for rapid antibody reduction.
procedureNeuropsychological rehabilitation
Cognitive rehabilitation therapy addressing memory deficits, emotional regulation, and behavioral changes resulting from limbic system involvement. Includes coping strategies and family education.
psychologicalLong-term neurological follow-up
Extended monitoring of neurological function, antibody titers, and potential relapse signs. Regular cognitive assessments to track recovery and identify persistent deficits.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Limbic Encephalitis With Dpp6 Antibodies C4750833?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Limbic Encephalitis With Dpp6 Antibodies C4750833. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy